The pending securities fraud class action lawsuit against PACS Group, Inc. is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The high relevance and importance are due to the direct involvement of the company in the lawsuit, which could lead to financial repercussions and affect investor sentiment.